RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules, USP, 60mg, 1,000-count bottles, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-748-10.

This recall is currently active, issued August 13, 2025. It was issued by Breckenridge Pharmaceutical, Inc..

Company
Breckenridge Pharmaceutical, Inc.
Recall Initiated
July 15, 2025
Posted
August 13, 2025
Recall Number
D-0552-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,829 60-count bottles
Firm Location
Berkeley Heights, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessment limit

Distribution

U.S Nationwide

Lot / Code Info

Lot: 230836C, Exp.: 02/28/2026

More recalls by Breckenridge Pharmaceutical, Inc.

View all recalls by this company →

Other recent Class II Drug recalls